AstraZeneca (AZ) is a global, innovation and research-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, renal, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.
AstraZeneca operates in over 100 countries. The innovative portfolio
of medicines of AstraZeneca are used by millions of patients worldwide.
Our contribution to the project
AZ will bring broad therapeutic area expertise as well as expertise in drug development with specialized knowledge and experience in patient safety. The AZ representatives will offer their extensive experience working with leading experts in their respective areas from health authorities, academia and industry and as such can bring to this project. a well-informed perspective.
AstraZeneca, Science newsreel
